Rumeysa Çinar

Rumeysa Çinar

Auto-generated profile, based on publicly available information

Rumeysa Çinar

Faculty of Medicine Department of Medical Biochemistry, Afyonkarahisar Health Sciences University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2025 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
RÇRumeysa Çınar
Rumeysa Çınar
ÖGÖzlem Kayacık Günday
Özlem Kayacık Günday
AKAhmet Kahraman
Ahmet Kahraman
MYMehmet Yılmazer
Mehmet Yılmazer
Objective: This study aims to explore the combined role of ANGPTL3, 4, 8, omentin-1, leptin, TNF-α, and IL-6 molecules known for their roles in fat metabolism, obesity, and inflammation, yet whose connection to PCOS is still debated in the development of PCOS. Methods: A prospective cross-sectional study involving PCOS patients (n=30) and BMI-matched controls (n=30) was conducted. Levels of ANGPTL3, 4, 8, omentin-1, leptin, TNF-α, and IL-6 were measured in peripheral venous blood samples. Results: When dividing both the PCOS and control groups into six BMI-based subgroups normal weight (20-24.9 kg/m²), slightly overweight (25-29.9 kg/m²), and obese (30-39.9 kg/m²) there were significant differences in levels of ANGPTL3 and 8, omentin-1, leptin, IL-6, and TNF-α (p<0.05). Comparison between the entire PCOS and control groups showed that CRP levels were significantly higher in the PCOS group (p<0.0001), while omentin-1 levels were significantly lower (p=0.022). Regression analysis, including ANGPTL3, 4, 8, IL-6, and TNF-α alongside CRP and omentin-1, indicated a significant model for PCOS (Nagelkerke R²=0.698, p<0.0001, PPV=80%, NPV=90%). In ROC analysis, the AUC for CRP and omentin-1 were significant (p<0.05; AUC=0.800-0.328). Conclusion: This study suggests a continuous interaction among ANGPTL, omentin-1, leptin, and cytokines in the etiopathogenesis of PCOS. How to cite

25 December 2025 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
JJale Akgöl
Jale Akgöl
ESEMİNE SARMAN
EMİNE SARMAN
RÇRumeysa Çinar
Rumeysa Çinar
Cisplatin is a widely used chemotherapeutic drug, but its side effects, especially liver and kidney toxicity, can limit its clinical use, and these adverse effects are mainly associated with oxidative stress and inflammation. Accordingly, this study aimed to investigate whether Crataegus monogyna (CM), a medicinal plant with antioxidant properties, can reduce cisplatin-induced damage in rats. Twenty-four male rats were divided into four groups: control, cisplatin-only (8 mg/kg, intraperitoneally), cisplatin + CM (200 mg/kg, orally), and CM-only. CM was administered for seven days, starting two days before the single cisplatin injection. Subsequently, blood samples were analyzed for liver enzymes (AST, ALT), kidney function markers (urea, creatinine), inflammatory cytokines (TNF-α, IL-6, IL-10, IFN-γ), and oxidative stress indicators (TAS, TOS). Liver and kidney tissues were also examined histologically and immunohistochemically for caspase-3, NF-κB-p65, TNF-α, and IL-6. As demonstrated by our findings, cisplatin significantly increased AST, ALT, urea, creatinine, TNF-α, IL-6, and TOS levels while reducing TAS. CM treatment alleviated these changes. Furthermore, tissue architecture was better preserved in the CM+CIS group compared to the CIS group, and fewer apoptotic and inflammatory cells were observed. No significant differences in IL-10 and IFN-γ levels were detected among the groups. Collectively, our findings suggest that CM may exert protective effects against cisplatin-induced liver and kidney toxicity, likely through its antioxidant and anti-inflammatory properties. CM may thus be considered as a supportive option to mitigate cisplatin-induced side effects.

27 January 2025 in Kocatepe Tıp Dergisi
Verified
Journal Article
Open access
PDF file
MEMüjgan Ercan
Müjgan Ercan
AEAyşe Ertekin
Ayşe Ertekin
ÖFÖzge Fenercioğlu
Özge Fenercioğlu
MOMehmet Ozcan
Mehmet Ozcan
RDRumeysa Duman
Rumeysa Duman
YEYasemin Engin
Yasemin Engin
AMAÇ: Kalite göstergeleri (KG), hata oranlarını azaltarak ve hasta güvenliğini koruyarak laboratuvar hizmetlerinin kalitesini iyileştirmek için kullanılan temel araçlardır. Çalışmamızda, acil servisten gelen ve reddedilen kan numunelerinin sayı ve oranları incelenerek IFCC’ nin (Uluslararası Klinik Kimya ve Laboratuvar Tıbbı Federasyonu) “Laboratuvar Hataları ve Hasta Güvenliği” Çalışma Grubu’nun (WG-LEPS) rapor ettiği kalite indekslerine göre karşılaştırılması amaçlandı. GEREÇ VE YÖNTEM: Acil servisten Klinik Biyokimya Laboratuvarı'na gelen kan numunelerinin sayılarını değerlendirmek için, 2022 yılına ait veriler Laboratuvar Bilgi Sistemi’nden (LBS) geriye dönük olarak alındı. Analiz öncesi aşamada, laboratuvara gelen kan örneklerinin sayıları, reddedilme nedenlerine göre gruplandırılarak aylık ve yıllık yüzdeleri hesaplandı. IFCC WG-LEPS’nin üç hedef kriterlerini içeren ölçütler (%25’lik yüksek performans, %50’lik orta dereceli performans ve %75’lik düşük performans) kapsamında değerlendirildi. BULGULAR: Toplam numune ret oranı % 2,3 olarak hesaplanmıştır. Reddedilme nedenlerine göre “hemolizli numune”, “uygun olmayan numune kabı”, “uygun olmayan numune miktarı” ve “pıhtılı numune”’ lerin % KG değerleri sırasıyla 0,72, 0,03, 0,77 ve 0,80 olarak belirlendi. SONUÇ: Laboratuvarımızın “hemolizli numune” ve “uygun olmayan numune kabı’’ için % KG’sinin düşük performansa sahip olduğu gösterildi. “Pıhtılı numune” ve “uygun olmayan numune miktarı” için % KG’lerinin kabul edilemez aralıkta olduğu tespit edildi. Sonuç olarak, numune alımı ve transferi konularındaki eğitimlerin sıklığı artırılarak, sürecin kalitesinin artırılacağı düşüncesindeyiz.